Aminopyrimidine derivatives as cyclin-dependent kinase inhibitors
US12338248B2 · kind B2 · utility
0Cited by
3References
48Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 22, 2024 |
| Grant date | Jun 24, 2025 |
| Priority date | — |
| Expiry date | Jul 22, 2044 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to novel CDK inhibitors, pharmaceutical compositions containing such compounds, and their use in prevention and treatment of diseases and conditions associated with CDK.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.